Emmanuel Drouin | Phantom limb phenomenon | Best Researcher Award

Assist Prof Dr. Emmanuel Drouin | Phantom limb phenomenon | Best Researcher Award

šŸ‘Øā€šŸ« Dr. Emmanuel Drouin, an esteemed figure in the field, currently serves as a Lecturer in the History of Medicine at the Faculty of Medicine of the Catholic University of Lille since September 2021. šŸ„ His diverse professional journey includes being the Director General of the Maternity of the Holy Family in Bethlehem, overseeing a Level III maternity with 5000 annual deliveries. šŸ¤° Prior to this, he played a pivotal role in healthcare administration, notably as the Departmental Delegate in the Regional Health Agency from 2016 to 2018, shaping health policies and leading initiatives. šŸŒ Dr. Drouin’s extensive experience encompasses roles in hospital efficiency, cancer research management, and leadership at the National Veterinary and Agri-Food School. šŸ†šŸ’”

Profile:

Scopus

Professional Experience:

šŸ‘Øā€āš•ļø Dr. Emmanuel Drouin is a seasoned professional with a diverse career spanning leadership roles in healthcare and academia. Currently a Lecturer in the History of Medicine at the Faculty of Medicine of the Catholic University of Lille since September 2021, he previously held the position of Director General of the Maternity of the Holy Family in Bethlehem, overseeing 5000 annual deliveries.

His extensive background includes serving as a Departmental Delegate in the Regional Health Agency, shaping health policies and negotiating CH CREFs. Dr. Drouin’s impactful journey also includes roles as Deputy to the Director General at the National Veterinary and Agri-Food School, Secretary General of the GIP CancĆ©ropĆ“le Grand Ouest, and Director of Efficiency for hospital organizations.

In addition, he has a rich history in clinical and research settings, serving as a Laboratory Director at Laennec TEK and as the General Director of the Notre Dame de GrĆ¢ces Clinic in Nantes. His post-doctorate involved clinical research in the Pediatric Intensive Care Unit, contributing to national clinical research hospital projects.

Throughout, Dr. Drouin has showcased leadership, financial acumen, and dedication to advancing medical knowledge. šŸ„šŸ‘Øā€šŸ”¬šŸ’”

Awards and Recognition:

šŸŒŸ Dr. Emmanuel Drouin, a distinguished individual, has not only excelled in the medical field but also achieved remarkable feats outside academia. šŸ† He was honored with a doctoral scholarship from the Departmental Council of Loire Atlantique in 1991, showcasing early recognition of his academic prowess. šŸŽ“

In collaboration with Nobel Prize winner Professor Jean Marie LEHN, he co-won the 6th National Competition for innovative technology companies, securing a substantial prize of 450,000 euros. šŸš€ This success led to the creation of a groundbreaking startup, demonstrating Dr. Drouin’s entrepreneurial spirit.

His accomplishments extend to being a Laureate of the National Academy of Medicine in 2013, a testament to his significant contributions to the medical field. šŸ„

Beyond his professional achievements, Dr. Drouin actively contributes to various medical societies, serving as a Member of the Board of Directors for the French Society for the History of Medicine, the French Society of Disaster Medicine, and the Medical Psychological Society. šŸ¤šŸŒ

His multifaceted engagement reflects a commitment not only to medical excellence but also to the broader societal impact of healthcare and research. šŸ‘Øā€āš•ļøāœØ

Publication:

  • “An Old but Still Relevant Question: Why Are Specific Muscles More Involved in Some Myopathies?”
    • Year: 2023
    • Authors: Drouin, E., Magot, A., PĆ©rĆ©on, Y.
    • Journal: Revue Neurologique
    • šŸ“–šŸ”¬
  • “The Microglial Hypothesis of Multiple Sclerosis”
    • Year: 2023
    • Authors: Hautecoeur, P., Kwiatkowski, A., Drouin, E.
    • Journal: The Lancet Neurology
    • šŸ“–šŸ”¬
  • “Sigmund Freud’s Shift”
    • Year: 2023
    • Authors: Drouin, E., Hendrickx, M., Hautecoeur, P.
    • Journal: The Lancet Neurology
    • šŸ“–šŸ”¬
  • “DĆ¼hrssen’s Cervical Incision: An Old Story”
    • Year: 2023
    • Authors: Drouin, E., Classe, J.-M., Descamps, P.
    • Journal: European Journal of Obstetrics and Gynecology and Reproductive Biology
    • šŸ“–šŸ”¬
  • “On a Case of Demonic Possession by Jean Lhermitte | Sur un Cas de Possession DĆ©moniaque par Jean Lhermitte”
    • Year: 2023
    • Authors: Drouin, E., Hautecoeur, P.
    • Journal: Annales Medico-Psychologiques
    • šŸ“–šŸ”¬
  • “125 Years of the Wertheim Operation. What Next?”
    • Year: 2023
    • Authors: Drouin, E., Classe, J.-M., Hautecoeur, P.
    • Journal: Journal of Medicine and Life
    • šŸ“–šŸ”¬
  • “Voices from the Past: The Pioneering Use of the Phonograph in Neurology”
    • Year: 2023
    • Authors: Brigo, F., Lorusso, L., Walusinski, O., Drouin, E.
    • Journal: Revue Neurologique
    • šŸ“–šŸ”¬
  • “Pr Jean Delay’s Triptych | Le Triptyque du Pr Jean Delay”
    • Year: 2023
    • Authors: Drouin, E., Hautecoeur, P.
    • Journal: Annales Medico-Psychologiques
    • šŸ“–šŸ”¬
  • “What You Feel Is Not Always What You’ve Got. Jean Lhermitte (1877ā€“1959) and the Phantom Limb Phenomenon”
    • Year: 2023 (Article in Press)
    • Authors: Drouin, E., Tatu, L., Hautecoeur, P.
    • Journal: Revue Neurologique
    • šŸ“–šŸ”¬
  • “Empathy in Medicine: A Ritualistic Healing Function? | L’empathie en MĆ©decine: Une Fonction Rituelle de GuĆ©rison?”
    • Year: 2023 (Article in Press)
    • Authors: Hendrickx, M., Hautecoeur, P., Drouin, E.
    • Journal: Encephale
    • šŸ“–šŸ”¬

 

 

 

 

Kenneth Blum | Dopaminedysregulation in Neurology | Best Researcher Award

Prof. Kenneth Blum: Dopaminedysregulation in Neurology

Kenneth Blum šŸ§¬šŸ”¬, a distinguished U.S. citizen šŸ‡ŗšŸ‡ø, Dopaminedysregulation in Neurology , boasts a robust academic journey culminating in a Ph.D. in Pharmacology from New York Medical College. With a wealth of expertise, he embarked on a fruitful postdoctoral stint at the Texas Biomedical Research Institute, delving into Psychopharmacology. Currently a Full Professor at Western University Health Sciences, his influence extends across diverse academic roles, including Adjunct Professor at Wright University and Research Professor Adjunct at the University of Vermont. Recognized as a trailblazer, he’s earned accolades like “Top 100 Scientist of the Year” and delivered keynote addresses globally, shaping the landscape of neuroscience and addiction research šŸŒšŸ§ .

Profile:

Scopus

šŸŽ“Ā Education:

Kenneth Blum šŸŽ“, a luminary in the field, earned his B.S. in Pharmacy from Columbia University in 1961 šŸ›ļø. He delved deeper into the realm of academia, achieving an M.S. in Medical Science from The University of Medicine and Dentistry of New Jersey in 1965 šŸ§Ŗ. Driven by passion, he secured a Ph.D. in Pharmacology from New York Medical College in 1968, guided by mentor Joseph Siefter šŸ§ . His journey continued with a pivotal postdoctoral stint at the Texas Biomedical Research Institute, focusing on Psychopharmacology in 1972 šŸŒ. Later, a Fellowship in Genetics at the University of Colorado School of Pharmacy in 1978 added another dimension to his illustrious career šŸ§¬.

šŸ„Ā Experience:

Kenneth Blum šŸŒšŸ§¬, a versatile professional, has left an indelible mark in academia and business. Notably appointed at the University of Texas Health Science Center at San Antonio, he contributed to various committees, including the Promotions Committee and International Relations Committee šŸŽ“. His leadership extends to diverse organizations, serving as Chairman for projects like the Hanging Bottle Research Project. In the business realm, Dr. Blum has held prominent roles, from Vice President of Research & Development at Zephra Corporation to Chairman & President of Pharmabyte Inc. His extensive advisory roles span across renowned entities like Weider International and PharmaVite Inc. šŸ¢šŸ”¬. As the Chief Scientific Officer for various healthcare centers, including Summit Estate Recovery Center and The Shores Recovery and Treatment Center, he continues to shape advancements in neurogenetics and addiction therapy. Currently, he holds the position of Executive Chairman at IngenEus, showcasing his enduring commitment to scientific innovation.

šŸ†Award & Honours:

 

Kenneth Blum šŸ…, a trailblazer in research and academia, boasts a plethora of prestigious honors and awards spanning his illustrious career. Recognized as the “Top 100 Registry Scientist of the Year” in 2019, he has graced global stages as a keynote speaker, addressing influential conferences on neuroscience, addiction, and genetics šŸ—£ļøšŸŒ. With a lifetime of achievements, Dr. Blum’s accolades include the “Who’s Who” Lifetime Achievement Award, the American Society of Addiction Medicine Millennium Lab Award, and the Julius Axelrod Distinguished Speaker Award. His impact extends beyond borders, with awards like the Titan Award and Marquis Who’s Who in America recognizing his expertise and contributions to addiction research šŸŒŸšŸ§¬.
šŸ’”Research Scholarships:

Kenneth Blum šŸ§¬šŸ”, a prolific researcher, has secured an impressive array of grants and contracts throughout his career, showcasing his commitment to advancing scientific knowledge. Notable achievements include his work on the “Psychogenetics of Drug Seeking Behavior” funded by NIDA, exploring genetic aspects of substance abuse šŸ’ŠšŸ§¬. Dr. Blum’s contributions extend to areas like alcoholism, hormones, and menopause, with grants from entities such as the Seaver Foundation and the Southwest Research Institute šŸ·šŸ¤°. His diverse research portfolio, spanning from the analysis of psychoactive drugs to finding genetic links to alcoholism, reflects a lifelong dedication to unraveling complex scientific puzzles šŸ”¬šŸŒ.

šŸ”¬Publications:
  1. The Future is Now for Precision Genomic Addiction Medicine as a Front-line Modality for Inducing ā€œDopamine Homeostasisā€ in Reward Deficiency Syndrome (RDS)
    • Authors: Gilley, E.D., Bowirrat, A., Gupta, A., Baron, D., Blum, K.
    • Year: 2024
  2. Dopaminergic dysfunction: Role for genetic & epigenetic testing in the new psychiatry
    • Authors: Blum, K., Ashford, J.W., Kateb, B., Makale, M., Gold, M.S.
    • Year: 2023
  3. Genetic Correlates as a Predictor of Bariatric Surgery Outcomes after 1 Year
    • Authors: Thanos, P.K., Hanna, C., Mihalkovic, A., Mastrandrea, L.D., Quattrin, T.
    • Year: 2023
  4. Preliminary Observations of Personalized Repetitive Magnetic Stimulation (PrTMS) Guided by EEG Spectra for Concussion
    • Authors: Makale, M.T., Nybo, C., Keifer, J., Thanos, P.K., Murphy, K.T.
    • Year: 2023
  5. Personalized repetitive transcranial magnetic stimulation (prtmsĀ®) for post-traumatic stress disorder (ptsd) in military combat veterans
    • Authors: Makale, M.T., Abbasi, S., Nybo, C., Dennen, C.A., Murphy, K.T.
    • Year: 2023
  6. The First Exploratory Personalized Medicine Approach to Improve Bariatric Surgery Outcomes Utilizing Psychosocial and Genetic Risk Assessments: Encouraging Clinical Research
    • Authors: Thanos, P.K., Hanna, C., Mihalkovic, A., Mastrandrea, L.D., Quattrin, T.
    • Year: 2023
  7. Behavioral, Neurochemical and Developmental Effects of Chronic Oral Methylphenidate: A Review
    • Authors: Senior, D., Ahmed, R., Arnavut, E., Badgaiyan, R.D., Thanos, P.K.
    • Year: 2023
  8. Positive Clinical Outcomes for Severe Reported Pain Using Robust Non-Addictive Home Electrotherapyā€”A Case-Series
    • Authors: Bajaj, A., Han, D., Elman, I., Barh, D., Blum, K.
    • Year: 2023
  9. Futuristic Exploration of Addiction Neuroscience in the Genomic Era
    • Authors: Blum, K., Elman, I., Bowirrat, A., Badgaiyan, R.D., Gold, M.S.
    • Year: 2023
  10. Neurogenetics and Epigenetics of Loneliness
    • Authors: Bowirrat, A., Elman, I., Dennen, C.A., Murphy, K.T., Blum, K.
    • Year: 2023